SHE:300639 Revenue

In the year 2024, Guangdong Hybribio Biotech had annual revenue of 815.53M CNY, down -26.16%. Guangdong Hybribio Biotech had revenue of 205.28M in the quarter ending December 31, 2024, a decrease of -19.12%.

Revenue

815.53M

Revenue Growth

-26.16%

P/S Ratio

3.98

Revenue / Employee

305.56K

Employees

2,669

Market Cap

3.24B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	815.53M	-288.93M	-26.16%
Dec 31, 2023	1.10B	-4.49B	-80.27%
Jan 1, 2023	5.60B	2.92B	109.39%
Jan 1, 2022	2.67B	1.32B	97.34%
Dec 31, 2020	1.35B	625.10M	85.70%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.30B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings